Earlier quoted context omitted.
The EMA is? The EMA typically takes longer on average to approve a drug than the FDA.[1] And if you want to look up an EU scandal, check out the Servier and Mediator. Hundreds of deaths reports and it took France almost 20 years to pull it off the market.[2] [1] https://news.yale.edu/2017/04/05/fda-approves-drugs-more-qui... [2] https://www.fiercepharma.com/pharma/servier-faces-courtroom-... .
Sure but I'm thinking of different metrics here.Europe has a variety of competing EpiPen equivalents so no price gouging. They had beta-blockers approved a decade before they were available in the US, with a small risk of liver failure for that first drug true, but many, many more lives were saved than lost. They had sunscreen that stopped UV A a decade before the US because the FDA's test only looked at skin burning…
The beta-blockers is also valid, but back then (mid-20th century) the EMA (or constituent countries) were consistently approving faster than the FDA. It wasn’t until the 80’a when the FDA was revamped to be more like the EMA.
Regardless, even though some may prefer failures like Mediator or Thalidomide, I just don’t think there is the political appetite to tell folks “yeah, the drug turned out to hurt people, but that’s the price we pay for having faster approvals”.
Logically it makes sense, but when it’s your child who is hurt by a drug, people get very risk adverse very quickly.